{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T21:46:22Z","timestamp":1792014382727,"version":"4.4.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:00Z","timestamp":1791936000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:00Z","timestamp":1791936000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100012538","name":"Swedish Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012538","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      RAS pathway mutations occur in ~\u200940% of colorectal cancers (CRCs), with\n                      <jats:italic>KRAS-<\/jats:italic>\n                      and\n                      <jats:italic>BRAF-<\/jats:italic>\n                      mutant tumors exhibiting distinct mutational, transcriptional, and epigenetic landscapes. Advances in next-generation sequencing enable integrated analyses of multi-omics data, providing insight into their regulatory relationships. To define the molecular programs driven by RAS pathway mutations, we generated isogenic CRC cell models and profiled chromatin accessibility using ATAC-seq.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We performed ATAC-seq in isogenic HCT116 and RKO models. Mutation-associated changes in genes, regulatory elements, and signaling pathways were identified, together with inferred transcription factor (TF) binding activity. Clinical datasets were analyzed to assess whether features identified in the cell models were recapitulated in patient tumors and whether they were associated with clinical outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Isogenic CRC models segregated by RAS pathway mutation status at both epigenetic and transcriptomic levels. Mutation alterations modulated WNT signaling, accompanied by changes in RUNX2 and TCF7L2 expression and binding activity. Comparison between the HCT116 and RKO models identified 85 genes, eight of which displayed reproducible expression patterns across three independent clinical cohorts. TCF7L2 were associated with RAS pathway mutations in patient tumors, with elevated expression level predicting worse overall survival independent of cofactors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      We identified RAS pathway mutation\u2013driven regulatory reprogramming with convergent effects on WNT signaling. TCF7L2 emerged as a key TF, with elevated expression in\n                      <jats:italic>BRAF<\/jats:italic>\n                      -mutant tumors independently associated with poor clinical outcomes. These findings highlight a clinically relevant epigenetic mechanism linking RAS pathway mutations to CRC cell survival maintenance.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12964-026-03305-0","type":"journal-article","created":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:21:15Z","timestamp":1791994875000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["RAS pathway mutations orchestrate chromatin reconfiguration and transcriptional rewiring in colorectal cancer"],"prefix":"10.1186","volume":"24","author":[{"given":"Zhangjingyi","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Snehangshu","family":"Kundu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengwei","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric Cruz","family":"Davila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vamsi Krishna","family":"Polavarapu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ece","family":"Akcan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingqi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Sj\u00f6blom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,14]]},"reference":[{"key":"3305_CR1","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan D. Hallmarks of Cancer: New Dimensions. Cancer Discov. 2022;12:31\u201346.","journal-title":"Cancer Discov"},{"key":"3305_CR2","doi-asserted-by":"publisher","first-page":"eaal2380","DOI":"10.1126\/science.aal2380","volume":"357","author":"WA Flavahan","year":"2017","unstructured":"Flavahan WA, Gaskell E, Bernstein BE. Epigenetic plasticity and the hallmarks of cancer. Science. 2017;357:eaal2380.","journal-title":"Science"},{"key":"3305_CR3","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/s41586-022-05202-1","volume":"611","author":"T Heide","year":"2022","unstructured":"Heide T, et al. The co-evolution of the genome and epigenome in colorectal cancer. Nature. 2022;611:733\u201343.","journal-title":"Nature"},{"key":"3305_CR4","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.cell.2018.02.060","volume":"173","author":"MH Bailey","year":"2018","unstructured":"Bailey MH, et al. Comprehensive Characterization of Cancer Driver Genes and Mutations. Cell. 2018;173:371\u2013e38518.","journal-title":"Cell"},{"key":"3305_CR5","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/s41586-024-07747-9","volume":"633","author":"AJ Cornish","year":"2024","unstructured":"Cornish AJ, et al. The genomic landscape of 2,023 colorectal cancers. Nature. 2024;633:127\u201336.","journal-title":"Nature"},{"key":"3305_CR6","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41586-024-07769-3","volume":"633","author":"L Nunes","year":"2024","unstructured":"Nunes L, et al. Prognostic genome and transcriptome signatures in colorectal cancers. Nature. 2024;633:137\u201346.","journal-title":"Nature"},{"key":"3305_CR7","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1053\/j.gastro.2009.12.065","volume":"138","author":"MS Pino","year":"2010","unstructured":"Pino MS, Chung DC. The Chromosomal Instability Pathway in Colon Cancer. Gastroenterology. 2010;138:2059\u201372.","journal-title":"Gastroenterology"},{"key":"3305_CR8","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1038\/nm.3967","volume":"21","author":"J Guinney","year":"2015","unstructured":"Guinney J, et al. The consensus molecular subtypes of colorectal cancer. Nat Med. 2015;21:1350\u20136.","journal-title":"Nat Med"},{"key":"3305_CR9","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1136\/gut.2003.037671","volume":"53","author":"T Kambara","year":"2004","unstructured":"Kambara T. BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum. Gut. 2004;53:1137\u201344.","journal-title":"Gut"},{"key":"3305_CR10","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13073-017-0511-4","volume":"10","author":"S Kundu","year":"2018","unstructured":"Kundu S, et al. Linking FOXO3, NCOA3, and TCF7L2 to Ras pathway phenotypes through a genome-wide forward genetic screen in human colorectal cancer cells. Genome Med. 2018;10:2.","journal-title":"Genome Med"},{"key":"3305_CR11","doi-asserted-by":"publisher","first-page":"eaax0698","DOI":"10.1126\/sciadv.aax0698","volume":"5","author":"Z Zhao","year":"2019","unstructured":"Zhao Z, et al. \u03b2-Catenin\/Tcf7l2\u2013dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer. Sci Adv. 2019;5:eaax0698.","journal-title":"Sci Adv"},{"key":"3305_CR12","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1038\/s42255-024-01166-w","volume":"6","author":"M Nam","year":"2024","unstructured":"Nam M, et al. Glucose limitation protects cancer cells from apoptosis induced by pyrimidine restriction and replication inhibition. Nat Metab. 2024;6:2338\u201353.","journal-title":"Nat Metab"},{"key":"3305_CR13","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s12943-017-0691-y","volume":"16","author":"KCG Berg","year":"2017","unstructured":"Berg KCG, et al. Multi-omics of 34 colorectal cancer cell lines - a resource for biomedical studies. Mol Cancer. 2017;16:116.","journal-title":"Mol Cancer"},{"key":"3305_CR14","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1016\/j.cell.2012.11.026","volume":"151","author":"J Rosenbluh","year":"2012","unstructured":"Rosenbluh J, et al. \u03b2-Catenin-Driven Cancers Require a YAP1 Transcriptional Complex for Survival and Tumorigenesis. Cell. 2012;151:1457\u201373.","journal-title":"Cell"},{"key":"3305_CR15","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1038\/s41467-019-09898-0","volume":"10","author":"T Zhan","year":"2019","unstructured":"Zhan T, et al. MEK inhibitors activate Wnt signalling and induce stem cell plasticity in colorectal cancer. Nat Commun. 2019;10:2197.","journal-title":"Nat Commun"},{"key":"3305_CR16","doi-asserted-by":"publisher","first-page":"6422","DOI":"10.1038\/s41467-020-20222-z","volume":"11","author":"J Grinat","year":"2020","unstructured":"Grinat J, et al. The epigenetic regulator Mll1 is required for Wnt-driven intestinal tumorigenesis and cancer stemness. Nat Commun. 2020;11:6422.","journal-title":"Nat Commun"},{"key":"3305_CR17","doi-asserted-by":"publisher","first-page":"eabf2567","DOI":"10.1126\/sciadv.abf2567","volume":"7","author":"C Wan","year":"2021","unstructured":"Wan C, et al. Genome-scale CRISPR-Cas9 screen of Wnt\/\u03b2-catenin signaling identifies therapeutic targets for colorectal cancer. Sci Adv. 2021;7:eabf2567.","journal-title":"Sci Adv"},{"key":"3305_CR18","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1186\/s13046-021-02025-2","volume":"40","author":"S Kundu","year":"2021","unstructured":"Kundu S, et al. Common and mutation specific phenotypes of KRAS and BRAF mutations in colorectal cancer cells revealed by integrative -omics analysis. J Exp Clin Cancer Res. 2021;40:225.","journal-title":"J Exp Clin Cancer Res"},{"key":"3305_CR19","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1038\/nmeth.4396","volume":"14","author":"MR Corces","year":"2017","unstructured":"Corces MR, et al. An improved ATAC-seq protocol reduces background and enables interrogation of frozen tissues. Nat Methods. 2017;14:959\u201362.","journal-title":"Nat Methods"},{"key":"3305_CR20","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.1038\/s41467-022-29912-2","volume":"13","author":"X Lu","year":"2022","unstructured":"Lu X, et al. Cell-lineage controlled epigenetic regulation in glioblastoma stem cells determines functionally distinct subgroups and predicts patient survival. Nat Commun. 2022;13:2236.","journal-title":"Nat Commun"},{"key":"3305_CR21","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1038\/nmeth.2688","volume":"10","author":"JD Buenrostro","year":"2013","unstructured":"Buenrostro JD, Giresi PG, Zaba LC, Chang HY, Greenleaf WJ. Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position. Nat Methods. 2013;10:1213\u20138.","journal-title":"Nat Methods"},{"key":"3305_CR22","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.1923","volume":"9","author":"B Langmead","year":"2012","unstructured":"Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2. Nat Methods. 2012;9:357\u20139.","journal-title":"Nat Methods"},{"key":"3305_CR23","doi-asserted-by":"publisher","first-page":"R137","DOI":"10.1186\/gb-2008-9-9-r137","volume":"9","author":"Y Zhang","year":"2008","unstructured":"Zhang Y, et al. Model-based Analysis of ChIP-Seq (MACS). Genome Biol. 2008;9:R137.","journal-title":"Genome Biol"},{"key":"3305_CR24","doi-asserted-by":"publisher","first-page":"9354","DOI":"10.1038\/s41598-019-45839-z","volume":"9","author":"HM Amemiya","year":"2019","unstructured":"Amemiya HM, Kundaje A, Boyle AP. The ENCODE Blacklist: Identification of Problematic Regions of the Genome. Sci Rep. 2019;9:9354.","journal-title":"Sci Rep"},{"key":"3305_CR25","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1093\/bioinformatics\/btq033","volume":"26","author":"AR Quinlan","year":"2010","unstructured":"Quinlan AR, Hall IM. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics. 2010;26:841\u20132.","journal-title":"Bioinformatics"},{"key":"3305_CR26","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550.","journal-title":"Genome Biol"},{"key":"3305_CR27","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1093\/bioinformatics\/btv145","volume":"31","author":"G Yu","year":"2015","unstructured":"Yu G, Wang L-G, He Q-Y. ChIPseeker: an R\/Bioconductor package for ChIP peak annotation, comparison and visualization. Bioinformatics. 2015;31:2382\u20133.","journal-title":"Bioinformatics"},{"key":"3305_CR28","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang L-G, Han Y, He Q-Y. clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters. OMICS. 2012;16:284\u20137.","journal-title":"OMICS"},{"key":"3305_CR29","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1038\/nmeth.4401","volume":"14","author":"AN Schep","year":"2017","unstructured":"Schep AN, Wu B, Buenrostro JD, Greenleaf WJ. chromVAR: inferring transcription-factor-associated accessibility from single-cell epigenomic data. Nat Methods. 2017;14:975\u20138.","journal-title":"Nat Methods"},{"key":"3305_CR30","doi-asserted-by":"publisher","first-page":"4267","DOI":"10.1038\/s41467-020-18035-1","volume":"11","author":"M Bentsen","year":"2020","unstructured":"Bentsen M, et al. ATAC-seq footprinting unravels kinetics of transcription factor binding during zygotic genome activation. Nat Commun. 2020;11:4267.","journal-title":"Nat Commun"},{"key":"3305_CR31","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1038\/s41591-023-02324-5","volume":"29","author":"J Roelands","year":"2023","unstructured":"Roelands J, et al. An integrated tumor, immune and microbiome atlas of colon cancer. Nat Med. 2023;29:1273\u201386.","journal-title":"Nat Med"},{"key":"3305_CR32","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.ccell.2015.08.001","volume":"28","author":"Z Yao","year":"2015","unstructured":"Yao Z, et al. BRAF Mutants Evade ERK-Dependent Feedback by Different Mechanisms that Determine Their Sensitivity to Pharmacologic Inhibition. Cancer Cell. 2015;28:370\u201383.","journal-title":"Cancer Cell"},{"key":"3305_CR33","doi-asserted-by":"publisher","first-page":"eado8758","DOI":"10.1126\/sciimmunol.ado8758","volume":"9","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, et al. Oncogenic KRAS drives immunosuppression of colorectal cancer by impairing DDX60-mediated dsRNA accumulation and viral mimicry. Sci Immunol. 2024;9:eado8758.","journal-title":"Sci Immunol"},{"key":"3305_CR34","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1038\/onc.2015.186","volume":"35","author":"J Cisowski","year":"2016","unstructured":"Cisowski J, Sayin VI, Liu M, Karlsson C, Bergo MO. Oncogene-induced senescence underlies the mutual exclusive nature of oncogenic KRAS and BRAF. Oncogene. 2016;35:1328\u201333.","journal-title":"Oncogene"},{"key":"3305_CR35","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1126\/science.1174229","volume":"325","author":"J Yun","year":"2009","unstructured":"Yun J, et al. Glucose Deprivation Contributes to the Development of KRAS Pathway Mutations in Tumor Cells. Science. 2009;325:1555\u20139.","journal-title":"Science"},{"key":"3305_CR36","doi-asserted-by":"publisher","first-page":"6262","DOI":"10.1016\/j.cell.2021.11.031","volume":"184","author":"B Chen","year":"2021","unstructured":"Chen B, et al. Differential pre-malignant programs and microenvironment chart distinct paths to malignancy in human colorectal polyps. Cell. 2021;184:6262\u2013e628026.","journal-title":"Cell"},{"key":"3305_CR37","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.ccell.2019.01.005","volume":"35","author":"Y Tao","year":"2019","unstructured":"Tao Y, et al. Aging-like Spontaneous Epigenetic Silencing Facilitates Wnt Activation, Stemness, and BrafV600E-Induced Tumorigenesis. Cancer Cell. 2019;35:315\u2013e3286.","journal-title":"Cancer Cell"},{"key":"3305_CR38","doi-asserted-by":"publisher","first-page":"112708","DOI":"10.1016\/j.isci.2025.112708","volume":"28","author":"L El Bouazzaoui","year":"2025","unstructured":"El Bouazzaoui L, et al. BRAFV600E augments WNT signaling in colorectal cancer via aberrant DNA methylation. iScience. 2025;28:112708.","journal-title":"iScience"},{"key":"3305_CR39","doi-asserted-by":"publisher","first-page":"3458","DOI":"10.1038\/s41388-020-1232-5","volume":"39","author":"S Li","year":"2020","unstructured":"Li S, et al. Commonly observed RNF43 mutations retain functionality in attenuating Wnt\/\u03b2-catenin signaling and unlikely confer Wnt-dependency onto colorectal cancers. Oncogene. 2020;39:3458\u201372.","journal-title":"Oncogene"},{"key":"3305_CR40","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.15252\/embj.201796662","volume":"36","author":"FR Dejure","year":"2017","unstructured":"Dejure FR, et al. The MYC mRNA 3\u2032-UTR couples RNA polymerase II function to glutamine and ribonucleotide levels. EMBO J. 2017;36:1854\u201368.","journal-title":"EMBO J"},{"key":"3305_CR41","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1038\/s41556-019-0408-0","volume":"21","author":"S Schmidt","year":"2019","unstructured":"Schmidt S, et al. A MYC\u2013GCN2\u2013eIF2\u03b1 negative feedback loop limits protein synthesis to prevent MYC-dependent apoptosis in colorectal cancer. Nat Cell Biol. 2019;21:1413\u201324.","journal-title":"Nat Cell Biol"},{"key":"3305_CR42","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1126\/science.281.5382.1509","volume":"281","author":"T-C He","year":"1998","unstructured":"He T-C, et al. Identification of c- MYC as a Target of the APC Pathway. Science. 1998;281:1509\u201312.","journal-title":"Science"},{"key":"3305_CR43","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41416-019-0477-7","volume":"121","author":"T Charitou","year":"2019","unstructured":"Charitou T, et al. Transcriptional and metabolic rewiring of colorectal cancer cells expressing the oncogenic KRASG13D mutation. Br J Cancer. 2019;121:37\u201350.","journal-title":"Br J Cancer"},{"key":"3305_CR44","doi-asserted-by":"publisher","first-page":"17995","DOI":"10.18632\/oncotarget.14929","volume":"8","author":"I Ischenko","year":"2017","unstructured":"Ischenko I, Zhi J, Hayman MJ, Petrenko O. KRAS-dependent suppression of MYC enhances the sensitivity of cancer cells to cytotoxic agents. Oncotarget. 2017;8:17995\u20138009.","journal-title":"Oncotarget"},{"key":"3305_CR45","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.cell.2011.08.017","volume":"146","author":"JE Delmore","year":"2011","unstructured":"Delmore JE, et al. BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc. Cell. 2011;146:904\u201317.","journal-title":"Cell"},{"key":"3305_CR46","doi-asserted-by":"publisher","unstructured":"Scott Kopetz HML. Reprogramming of Cellular Plasticity via ETS and MYC Core-regulatory Circuits During Response to MAPK Inhibition in BRAF-mutant Colorectal Cancer. Preprint at https:\/\/doi.org\/https:\/\/doi.org\/10.1101\/2025.06.15.659716","DOI":"10.1101\/2025.06.15.659716"},{"key":"3305_CR47","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/s41418-019-0363-0","volume":"27","author":"Q Zhang","year":"2020","unstructured":"Zhang Q, et al. The MAP3K13-TRIM25-FBXW7\u03b1 axis affects c-Myc protein stability and tumor development. Cell Death Differ. 2020;27:420\u201333.","journal-title":"Cell Death Differ"},{"key":"3305_CR48","doi-asserted-by":"publisher","first-page":"33132","DOI":"10.1074\/jbc.M500608200","volume":"280","author":"T Gaur","year":"2005","unstructured":"Gaur T, et al. Canonical WNT Signaling Promotes Osteogenesis by Directly Stimulating Runx2 Gene Expression. J Biol Chem. 2005;280:33132\u201340.","journal-title":"J Biol Chem"},{"key":"3305_CR49","doi-asserted-by":"publisher","first-page":"3893","DOI":"10.1038\/s41388-020-1259-7","volume":"39","author":"J Wenzel","year":"2020","unstructured":"Wenzel J, et al. Loss of the nuclear Wnt pathway effector TCF7L2 promotes migration and invasion of human colorectal cancer cells. Oncogene. 2020;39:3893\u2013909.","journal-title":"Oncogene"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-026-03305-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-026-03305-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-026-03305-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:57:06Z","timestamp":1792011426000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-026-03305-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,14]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3305"],"URL":"https:\/\/doi.org\/10.1186\/s12964-026-03305-0","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,14]]},"assertion":[{"value":"15 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted using publicly available data from two previously published studies: Nunes et al., Nature 2024 [\n                      \n                      ] and Roelands et al., Nature Medicine 2023 [\n                      \n                      ], and TCGA COAD cohorts from GDC portal. Ethical approvals were obtained from the respective institutional review boards, and all participants provided informed consent, as described in the original publications. No new data was collected specifically for this study, and no additional ethical approval was required.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"553"}}